Show simple item record

dc.contributor.authorMbaveng, Armelle T
dc.contributor.authorOmosa, Leonidah K
dc.contributor.authorBitchagno, Gabin T.M
dc.contributor.authorKuete, Jenifer R.N
dc.contributor.authorNchiozem-Ngnitedem, Vaderament-A
dc.contributor.authorKuete, Victor
dc.date.accessioned2023-05-22T05:50:59Z
dc.date.available2023-05-22T05:50:59Z
dc.date.issued2022
dc.identifier.citationMbaveng AT, Omosa LK, Omosa LK, Kuete JR, Nchiozem-Ngnitedem VA, Kuete V. "Potential antibacterial pharmaceuticals from the flora of Africa.". In: Advances in Botanical Research . https://doi.org/10.1016/bs.abr.2022.08.021: Elsevier; 2022.en_US
dc.identifier.urihttp://erepository.uonbi.ac.ke/handle/11295/163634
dc.description.abstractThe present chapter highlights the antibacterial potential of nine highly active compounds isolated from the African medicinal plants: 8,8-bis-(dihydroconiferyl)- diferulate, buesgenine, candidone, diospyrone, ferruginin A, isobavachalcone, neo- bavaisoflavone, neocyclomorusin, and plumbagin. Their botanical source as well as their hypothetical biosynthetic pathways have also been discussed. Regarding their inhibitory potential towards the Gram-negative and Gram-positive bacteria, and mycobacteria, the above phytochemicals constitute potential pharmaceuticals that deserve clinical studies to develop antibacterial drugs to combat bacterial infections involving both drug-sensitive and drug-resistant phenotypes.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.titlePotential Antibacterial Pharmaceuticals From the Flora of Africaen_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States